PFM Health Sciences’s T-Mobile US TMUS Stock Holding History

PFM Health Sciences’s Portfolio TMUS Stock Details TMUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-93,378	Closed	-$5.37M	–	117
2016 Q4	$5.37M	Sell	93,378 -324,738	-78%	-$17M	0.15%	88
2016 Q3	$19.5M	Buy	+418,116	New	+$19.2M	0.57%	58

Other funds holding TMUS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PFM Health Sciences's TMUS Position: Q1 2017 in Review

PFM Health Sciences sold out of T-Mobile US (TMUS) in Q1 2017, closing a stake of 93,378 shares — an estimated $5.37M sold.

PFM Health Sciences first reported a position in TMUS in Q3 2016 and held it in 2 quarters. The position peaked at $19.5M in Q3 2016. 538 funds tracked by Wall St. Rank hold TMUS as of Q1 2017.

PFM Health Sciences reported no remaining T-Mobile US position as of Q1 2017 after selling out during the quarter.
PFM Health Sciences sold 93,378 T-Mobile US shares in Q1 2017, an estimated $5.37M.
PFM Health Sciences first reported a position in T-Mobile US in Q3 2016 and held it in 2 quarters.
PFM Health Sciences's T-Mobile US position peaked at $19.5M in Q3 2016.
538 funds tracked by Wall St. Rank held T-Mobile US as of Q1 2017.

Based on PFM Health Sciences's 13F filing for Q1 2017, filed 15 May 2017.